Stricter shelf life rule a bitter pill to swallow for pharma companies

A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the Indian pharmaceutical industry. Manufacturers are now forced to destroy stocks to comply with this rule. The industry is urging for a revision, citing unnecessary losses and questioning the need when importing countries permit shorter shelf lives.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dGhcLye
via IFTTT